Related Experiment Video
Updated: Jun 22, 2026
Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
Published on: August 23, 2022
Increased MMP-3 and CTGF expression during lipopolysaccharide-induced dopaminergic neurodegeneration
Justin A McClain1, Linda L Phillips, Helen L Fillmore
1Virginia Commonwealth University, Department of Physiology and Biophysics, United States.
Abstract:
Accumulating evidence indicates that neuroinflammation contributes significantly to progressive dopaminergic (DA) neurodegeneration in Parkinson's disease (PD). Altered matrix metalloproteinase-3 (MMP-3) expression has been reported in several neuroinflammatory paradigms; however, its relationship to inflammation-induced DA neurotoxicity has not been explored. To this end, we investigated the temporal expression pattern of MMP-3 and one of its downstream targets, connective tissue growth factor (CTGF), following lipopolysaccharide (LPS)-induced DA neurodegeneration. LPS was directly injected into the substantia nigra of male Sprague-Dawley rats. Lesion formation was confirmed with immunohistochemistry 48 h post-injection. MMP-3 and CTGF were measured by western blot 12, 24, and 48 h post-injection. In association with neurodegeneration, MMP-3 expression and activation was significantly increased 24 and 48 h after LPS injection. In addition, CTGF expression increased 5-fold at the 24h time point. The temporal changes in MMP-3 and CTGF expression corresponded to the neurodegenerative phase of this model, suggesting that these two proteins may participate in neuroinflammation-induced DA neurotoxicity.
Insights
Neuroinflammation in Parkinson's disease (PD) involves matrix metalloproteinase-3 (MMP-3) and connective tissue growth factor (CTGF). This study shows their expression increases with dopaminergic neurodegeneration in a rat model.
Area of Science:
- Neuroscience
- Pathology
- Biochemistry
Background:
- Neuroinflammation is a key factor in progressive dopaminergic (DA) neurodegeneration observed in Parkinson's disease (PD).
- The role of matrix metalloproteinase-3 (MMP-3) in inflammation-induced DA neurotoxicity remains unclear, despite its altered expression in other neuroinflammatory conditions.
Purpose of the Study:
- To investigate the temporal expression patterns of MMP-3 and connective tissue growth factor (CTGF) in response to lipopolysaccharide (LPS)-induced DA neurodegeneration.
- To explore the potential involvement of MMP-3 and CTGF in the neurotoxic processes associated with Parkinson's disease.
Main Methods:
- Lipopolysaccharide (LPS) was administered via direct injection into the substantia nigra of male Sprague-Dawley rats to induce DA neurodegeneration.
- Lesion formation was verified using immunohistochemistry 48 hours post-injection.
- MMP-3 and CTGF expression levels were quantified using western blot analysis at 12, 24, and 48 hours after LPS injection.
Main Results:
- MMP-3 expression and activation significantly increased at 24 and 48 hours post-LPS injection, coinciding with neurodegeneration.
- Connective tissue growth factor (CTGF) expression showed a notable 5-fold increase at the 24-hour time point.
- The observed temporal changes in MMP-3 and CTGF levels correlated with the progression of neurodegeneration in the studied model.
Conclusions:
- The study suggests that MMP-3 and CTGF are upregulated during the neurodegenerative phase of LPS-induced Parkinson's disease.
- These findings indicate a potential role for MMP-3 and CTGF in mediating neuroinflammation-induced dopaminergic neurotoxicity in Parkinson's disease.
- Further research is warranted to elucidate the precise mechanisms by which MMP-3 and CTGF contribute to Parkinson's disease pathogenesis.
